You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb573026 |
---|---|
Category | Small Molecules |
Description | Leniolisib (CDZ173) is a potent and selective PI3Kδ inhibitor currently in phase II/III clinical trials for the treatment of immunodeficiency disorders. |
CAS Number | [1354690-24-6] |
MW | 450.466 |
SMILES | FC(C1=C(N=C([H])C(=C1[H])N1C([H])([H])C([H])([H])C2=C(C1([H])[H])C(=NC([H])=N2)N([H])[C@]1([H])C([H])([H])N(C(C([H])([H])C([H])([H])[H])=O)C([H])([H])C1([H])[H])OC([H])([H])[H])(F)F |
Formula | C21H25F3N6O2 |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |